The Biotech Capital Compass
Biotechnology & ‘Fog of Valuation’ savant
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 191 | Founded | 2 years ago | Last Issue | 3 days ago |
| Active | |||||
Read this Newsletter
hartajsingh1.substack.comLatest Issues
BCC Then and Now, Part 1: Revisiting the First Compass
Revisiting the First Biotech Capital Compass
On June 17, 2024, I founded Tecumseh Partners. Four months later, on October 18, 2024, the first edition of Biotech Capital Compass (BCC) landed in readers’ inboxes.
We are also including th...
The Biotech Watchlist: From ASCO 2026 With Love
Strong science, selective stocks, and why conference season still matters for biotech investors.
Medical conferences are not trading rules, but they are powerful attention windows for biotechnology. In this Biotech Watchlist, we use the Am...
Video Companion: The Cost of Survival, Parts 2 & 3
In this Video Companion, we extend The Cost of Survival series from the healthcare financing mismatch identified in Part 1 into the more practical architecture explored in Parts 2 and 3. The central issue is temporal: modern therapies can c...
The Biotech Watchlist: The China Biotech Paradox
How rising scientific integration and growing geopolitical separation are reshaping the global biotechnology ecosystem.
China’s biotechnology sector has evolved from a manufacturing and generics-driven industry into a major source of scien...
Biotech Watchlist: ASCO Ends, Volatility Returns
ASCO Ends, Volatility Returns
The biotech sector reminded investors this week why it remains one of the market’s most volatile corners.
Following the conclusion of the American Society of Clinical Oncology (ASCO) annual meeting in Chic...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for The Biotech Capital Compass.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Biotech Capital Compass breaks down complex biotech stories into valuation, risk, and narrative frameworks investors can use. Written by Hartaj Singh, a biotech analyst focused on translating innovation into investment reality.
Frequently Asked Questions
How can I access the email archive for The Biotech Capital Compass?
You can find recent issues that have been published by The Biotech Capital Compass on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The Biotech Capital Compass have?
To see how many people subscribe to The Biotech Capital Compass, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The Biotech Capital Compass?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Biotech Capital Compass as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The Biotech Capital Compass?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Biotech Capital Compass using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to The Biotech Capital Compass?
Scroll up to where it says Related Newsletters to see other publications like The Biotech Capital Compass. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The Biotech Capital Compass?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.